1,3-Benzodioxolyl-N-ethylbutanamine

Psychoactive drug From Wikipedia, the free encyclopedia

EBDB, also known as 1,3-benzodioxolyl-N-ethylbutanamine, 3,4-methylenedioxy-α,N-diethylphenethylamine, or ethyl-J, is a psychoactive drug of the phenethylamine, phenylisobutylamine, and MDxx families.[1][2][3] It is the N-ethyl analogue of BDB (J) and the α-ethyl analogue of MDEA.[1]

Other names1,3-Benzodioxolyl-N-ethylbutanamine; EBDB; 3,4-Methenedioxy-α,N-diethylphenethylamine
ATC code
  • None
Duration of action"Probably short"[1]
Quick facts Clinical data, Other names ...
EBDB
Clinical data
Other names1,3-Benzodioxolyl-N-ethylbutanamine; EBDB; 3,4-Methenedioxy-α,N-diethylphenethylamine
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of action"Probably short"[1]
Identifiers
  • 1-(2H-1,3-benzodioxol-5-yl)-N-ethylbutan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H19NO2
Molar mass221.300 g·mol−1
3D model (JSmol)
Melting point176 to 177 °C (349 to 351 °F)
  • O1c2ccc(cc2OC1)CC(NCC)CC
  • InChI=1S/C13H19NO2/c1-3-11(14-4-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3
  • Key:IYZPKSQJPVUWRO-UHFFFAOYSA-N
  (verify)
Close

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists EBDB's minimum dose as 90 mg orally and its duration as unknown.[1] It produced few to no effects at the tested doses.[1]

Chemistry

Synthesis

The chemical synthesis of EBDB has been described.[1]

See also

References

Related Articles

Wikiwand AI